PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sichuan Qianli-beoka Medical Technology Inc.

USPTO PatentsView assignee record — 71 granted patents across 0 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search.

Explore the portfolio See the ranking
71
Total patents granted
0
CPC technology areas
1.0
Avg claims per patent
—
5-year filing velocity

The verdict

Sichuan holds 71 US patents across 0 technology areas — rank #4,916 of 50,000 tracked assignees.

#4,916
of 50,000 US assignees by volume
Top 49%
by Innovation Score (35.4/100)
1.0
avg claims per patent

Portfolio overview

Sichuan Qianli-beoka Medical Technology Inc. has been granted 71 US utility patents between 2021 and 2025, placing Sichuan Qianli-beoka Medical Technology Inc. at rank #4,916 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a Foreign Corporation, Sichuan Qianli-beoka Medical Technology Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 35.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 71 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Sichuan Qianli-beoka Medical Technology Inc.'s 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 0 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sichuan Qianli-beoka Medical Technology Inc. against peers pursuing similar technology classes.

How does Sichuan compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Sichuan holds 71 patents — placing it at rank #4,916 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Sichuan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

35 Top 49% higher than 51% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

010203040 20212022202320242025 6
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Sichuan Qianli-beoka Medical Technology Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 8 11.3%
2022 4 5.6%
2023 21 29.6%
2024 32 45.1%
2025 6 8.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple

Where it ranks

Overall rank by patents

#4,916

Across all tracked assignees

Innovation Score

35.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Sichuan Qianli-beoka Medical Technology Inc. hold?
Sichuan Qianli-beoka Medical Technology Inc. holds 71 US granted patents filed between 2021 and 2025, spanning 0 technology areas.
What is Sichuan Qianli-beoka Medical Technology Inc.'s Innovation Score?
Sichuan Qianli-beoka Medical Technology Inc. has an Innovation Score of 35.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Sichuan Qianli-beoka Medical Technology Inc. focus on?
Sichuan Qianli-beoka Medical Technology Inc. has filed patents across 0 technology areas classified under the Cooperative Patent Classification system.
Is Sichuan Qianli-beoka Medical Technology Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Sichuan Qianli-beoka Medical Technology Inc..
What does claim depth mean for Sichuan Qianli-beoka Medical Technology Inc.'s patents?
Sichuan Qianli-beoka Medical Technology Inc.'s patents average 1.0 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Sichuan Qianli-beoka Medical Technology Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Sichuan's 71 grants land it in the top 49% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — Sichuan ranks #4,916 of 50,000. Top 50 holders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Top 50 patent holders

See where Sichuan Qianli-beoka Medical Technology Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov